Meetings - The ASCO Post

/ Navigating the Immunotherapy Landscape in Advanced Recurrent Endometrial Cancer

Case 3: Newly Diagnosed Advanced Uterine Papillary Serous Carcinoma

This is Part 3 of Navigating the Immunotherapy Landscape in Advanced/Recurrent Endometrial Cancer, a three-part video roundtable series. Scroll down to watch the other videos from this roundtable. ...

gynecologic cancers

/ Navigating the Immunotherapy Landscape in Advanced Recurrent Endometrial Cancer

Case 2: Newly Diagnosed Advanced MMRp Endometrioid Adenocarcinoma

This is Part 2 of Navigating the Immunotherapy Landscape in Advanced/Recurrent Endometrial Cancer, a three-part video roundtable series. Scroll down to watch the other videos from this roundtable. ...

gynecologic cancers

/ Navigating the Immunotherapy Landscape in Advanced Recurrent Endometrial Cancer

Case 1: Advanced and Recurrent MMRd Endometrioid Adenocarcinoma of the Uterus

This is Part 1 of Navigating the Immunotherapy Landscape in Advanced/Recurrent Endometrial Cancer, a three-part video roundtable series. Scroll down to watch the other videos from this roundtable. I...

Navigating the Immunotherapy Landscape in Advanced Recurrent Endometrial Cancer

Case 3: Newly Diagnosed Advanced Uterine Papillary Serous Carcinoma

Case 2: Newly Diagnosed Advanced MMRp Endometrioid Adenocarcinoma

Case 1: Advanced and Recurrent MMRd Endometrioid Adenocarcinoma of the Uterus

Long-Term Immunotherapy for Alveolar Soft Part Sarcoma

AMA Data Show Nearly 50 Percent of Surveyed Oncologists Reported Burnout in 2025

Unique Phase I NSCLC Trial Sites Decreasing in United States

Overall Survival With Addition of Relacorilant to Nab-Paclitaxel in Platinum-Resistant Ovarian Cancer

Tislelizumab With Induction Chemotherapy and Concurrent Chemoradiotherapy in Locally Advanced Esophageal Cancer